DE69609199T2 - Lacton derivate von 17.beta.-carboxy, carbothio und amide androstanverbindungen - Google Patents

Lacton derivate von 17.beta.-carboxy, carbothio und amide androstanverbindungen

Info

Publication number
DE69609199T2
DE69609199T2 DE69609199T DE69609199T DE69609199T2 DE 69609199 T2 DE69609199 T2 DE 69609199T2 DE 69609199 T DE69609199 T DE 69609199T DE 69609199 T DE69609199 T DE 69609199T DE 69609199 T2 DE69609199 T2 DE 69609199T2
Authority
DE
Germany
Prior art keywords
carbothio
lacton
carboxy
amide
beta
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69609199T
Other languages
English (en)
Other versions
DE69609199D1 (de
Inventor
Keith Biggadike
Panayiotis Alexandro Procopiou
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9526651.6A external-priority patent/GB9526651D0/en
Priority claimed from GBGB9613121.4A external-priority patent/GB9613121D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of DE69609199D1 publication Critical patent/DE69609199D1/de
Application granted granted Critical
Publication of DE69609199T2 publication Critical patent/DE69609199T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0066—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by a carbon atom forming part of an amide group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C07J3/005—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom the carbon atom being part of a carboxylic function
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69609199T 1995-12-29 1996-12-19 Lacton derivate von 17.beta.-carboxy, carbothio und amide androstanverbindungen Expired - Fee Related DE69609199T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9526651.6A GB9526651D0 (en) 1995-12-29 1995-12-29 Compounds
GBGB9613121.4A GB9613121D0 (en) 1996-06-21 1996-06-21 Compounds
PCT/GB1996/003140 WO1997024365A1 (en) 1995-12-29 1996-12-19 Lactone derivatives of 17.beta.-carboxy, carbothio and amide androstane derivatives

Publications (2)

Publication Number Publication Date
DE69609199D1 DE69609199D1 (de) 2000-08-10
DE69609199T2 true DE69609199T2 (de) 2001-03-01

Family

ID=26308402

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69609199T Expired - Fee Related DE69609199T2 (de) 1995-12-29 1996-12-19 Lacton derivate von 17.beta.-carboxy, carbothio und amide androstanverbindungen

Country Status (34)

Country Link
US (1) US6197761B1 (de)
EP (1) EP0876392B1 (de)
JP (1) JP2947944B2 (de)
KR (1) KR19990076859A (de)
CN (1) CN1133643C (de)
AP (1) AP9801274A0 (de)
AT (1) ATE194356T1 (de)
AU (1) AU721865B2 (de)
BG (1) BG102625A (de)
BR (1) BR9612309A (de)
CA (1) CA2241728A1 (de)
CZ (1) CZ207498A3 (de)
DE (1) DE69609199T2 (de)
DK (1) DK0876392T3 (de)
EA (1) EA001401B1 (de)
EE (1) EE9800227A (de)
ES (1) ES2150150T3 (de)
GR (1) GR3034564T3 (de)
HK (1) HK1012193A1 (de)
HU (1) HUP9903707A3 (de)
IL (1) IL124938A0 (de)
IS (1) IS4781A (de)
MX (1) MX9805181A (de)
NO (1) NO311022B1 (de)
NZ (1) NZ324373A (de)
OA (1) OA10701A (de)
PE (1) PE87598A1 (de)
PL (1) PL327629A1 (de)
PT (1) PT876392E (de)
SI (1) SI0876392T1 (de)
SK (1) SK89198A3 (de)
TR (1) TR199801247T2 (de)
TW (1) TW498072B (de)
WO (1) WO1997024365A1 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2215310T3 (es) * 1997-06-30 2004-10-01 Glaxo Group Limited Procedimiento para identificar compuestos que tienen una actividad sistemica reducida.
GB9909229D0 (en) * 1999-04-23 1999-06-16 Glaxo Group Ltd Enantiomers of mercapto lactones and processes for their synthesis
GB0017988D0 (en) * 2000-07-21 2000-09-13 Glaxo Group Ltd Novel process
US6858596B2 (en) * 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
US6750210B2 (en) 2000-08-05 2004-06-15 Smithkline Beecham Corporation Formulation containing novel anti-inflammatory androstane derivative
US6777399B2 (en) * 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6759398B2 (en) 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
US6787532B2 (en) 2000-08-05 2004-09-07 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivatives
US6777400B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
EA005992B1 (ru) * 2000-08-05 2005-08-25 Глаксо Груп Лимитед S-ФТОРМЕТИЛОВЫЙ ЭФИР 6α,9α-ДИФТОР-17α-[(2-ФУРАНИЛКАРБОНИЛ)ОКСИ]-11β-ГИДРОКСИ-16α-МЕТИЛ-3-ОКСОАНДРОСТА-1,4-ДИЕН-17β-КАРБОТИОКИСЛОТЫ В КАЧЕСТВЕ ПРОТИВОВОСПАЛИТЕЛЬНОГО АГЕНТА
GB0019172D0 (en) 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
US6858593B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
UA77656C2 (en) 2001-04-07 2007-01-15 Glaxo Group Ltd S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent
AU2002253342B2 (en) * 2001-04-30 2007-01-04 Glaxo Group Limited Novel anti-inflammatory androstane derivatives
ES2307751T3 (es) * 2001-06-12 2008-12-01 Glaxo Group Limited Nuevos esteres heterociclicos centi-inflamatorios 17 alfa de derivados 17 beta de carbotioato de androstano.
WO2003018575A1 (en) * 2001-08-24 2003-03-06 Wyeth Holdings Corporation 5-substituted-3(2h)-furanones useful for inhibition of farnesyl-protein transferase
GB0125259D0 (en) 2001-10-20 2001-12-12 Glaxo Group Ltd Novel compounds
WO2003042229A1 (en) * 2001-11-12 2003-05-22 Glaxo Group Limited Non-aromatic heterocyclic esters of furan-2-one-esters of 17.beta.-carboxyl or 17.beta.-carbothio glucocorticoids
GB0127160D0 (en) * 2001-11-12 2002-01-02 Glaxo Group Ltd Novel compounds
US20050175545A1 (en) * 2002-02-04 2005-08-11 Keith Biggadike Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist
GB0202635D0 (en) * 2002-02-05 2002-03-20 Glaxo Wellcome Mfg Pte Ltd Formulation containing novel anti-inflammatory androstane derivative
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
AU2004226318B2 (en) * 2003-04-04 2008-06-05 Xellia Pharmaceuticals Aps Process for the preparation of steroidal carbothioic acid derivatives and intermediates
EP1466920A1 (de) * 2003-04-04 2004-10-13 Alpharma APS Verfahren zur Herstellung von steroidal 17 beta-carbothioates
PT103202B (pt) 2004-10-19 2011-01-27 Hovione Farmaciencia S A Processo para a esterificação de um ácido carbotiótico
GB0507165D0 (en) * 2005-04-08 2005-05-18 Glaxo Group Ltd Novel crystalline pharmaceutical product
AR059216A1 (es) * 2006-01-27 2008-03-19 Sun Pharmaceutical Ind Ltd 11b-hidroxiandrosta-4-eno-3-onas
GB0615108D0 (en) * 2006-07-28 2006-09-06 Glaxo Group Ltd Novel formulations
CN103087137A (zh) * 2011-11-07 2013-05-08 天津金耀集团有限公司 一种21位为硫代烃基的糖皮质激素

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4093721A (en) * 1974-08-30 1978-06-06 Glaxo Laboratories Limited Pharmaceutical compositions of 6α,9α-difluoro-androst-4-ene-17β-carboxylates and derivatives thereof
US4188385A (en) * 1978-04-05 1980-02-12 Syntex (U.S.A.) Inc. Thioetianic acid derivatives
SE8306370D0 (sv) * 1983-11-18 1983-11-18 Draco Ab Novel androstane-17beta-carboxylic acid esters, a process and intermediates for their preparation, compositions and method for the treatment of inflammatory conditions
IL78144A0 (en) * 1985-04-04 1986-07-31 Draco Ab Novel androstane-17beta-carboxylic acid esters
US5767113A (en) * 1995-05-10 1998-06-16 The Salk Institute For Biological Studies Compounds useful for concurrently activating glucocorticoid-induced response and reducing multidrug resistance

Also Published As

Publication number Publication date
BG102625A (en) 1999-04-30
CZ207498A3 (cs) 1998-11-11
DE69609199D1 (de) 2000-08-10
EA199800484A1 (ru) 1999-02-25
HK1012193A1 (en) 1999-07-30
SI0876392T1 (en) 2000-12-31
NO311022B1 (no) 2001-10-01
JP2947944B2 (ja) 1999-09-13
AU721865B2 (en) 2000-07-13
HUP9903707A2 (hu) 2000-03-28
NO983004D0 (no) 1998-06-26
HUP9903707A3 (en) 2000-04-28
EA001401B1 (ru) 2001-02-26
BR9612309A (pt) 1999-07-13
NZ324373A (en) 1999-10-28
SK89198A3 (en) 1999-03-12
WO1997024365A1 (en) 1997-07-10
CA2241728A1 (en) 1997-07-10
CN1133643C (zh) 2004-01-07
GR3034564T3 (en) 2001-01-31
US6197761B1 (en) 2001-03-06
EP0876392A1 (de) 1998-11-11
CN1209135A (zh) 1999-02-24
PE87598A1 (es) 1999-01-15
OA10701A (en) 2002-05-21
ATE194356T1 (de) 2000-07-15
TW498072B (en) 2002-08-11
IS4781A (is) 1998-06-23
PL327629A1 (en) 1998-12-21
EP0876392B1 (de) 2000-07-05
EE9800227A (et) 1998-12-15
TR199801247T2 (xx) 1998-11-23
AU1140997A (en) 1997-07-28
JPH11501675A (ja) 1999-02-09
MX9805181A (es) 1998-10-31
PT876392E (pt) 2000-12-29
AP9801274A0 (en) 1998-06-30
KR19990076859A (ko) 1999-10-25
NO983004L (no) 1998-08-26
IL124938A0 (en) 1999-01-26
DK0876392T3 (da) 2000-11-06
ES2150150T3 (es) 2000-11-16

Similar Documents

Publication Publication Date Title
DE69609199T2 (de) Lacton derivate von 17.beta.-carboxy, carbothio und amide androstanverbindungen
ATE263147T1 (de) Derivate von aryloxyarylsulfonylamino hydroxyaminsäuren
DE69622148T2 (de) Chinazozin derivate und deren verwendung
PT1000048E (pt) Derivados substituidos do 1,2,3,4-tetrahidronaftaleno
ATE224910T1 (de) Derivate von dolestatin, deren herstellung und verwendung
DE69832982D1 (de) Dolastatin 15 derivate
DE69723398D1 (de) Polyalkylphenoxyaminoalkane und diese enthaltende freibstoffzusammensetzungen
DE69715482D1 (de) Herstellung von 1,1,1,3,3-Pentachlorbutan und von 1,1,1,3,3-Pentafluorbutan
DE69631774D1 (de) 2,3-dioxo-1,2,3,4-tetrahydro-chinoxalin derivate
DE69603269D1 (de) Derivate von inulin
PT921125E (pt) Derivados de 1,38-triaza-espiro 4,5 decan-4-ona
DE69513831D1 (de) Semicarbazid-derivate und diese enthaltende coatings
EE04681B1 (et) 3,6-poolketaalid 9a-asaliidide klassist, nende valmistamismeetod ja farmatseutiline kompositsioon
MA22916A1 (fr) Derives de 2-imidazoline-5-ones et 2-imidazoline-5-thiones fongicides.
NO960699L (no) Antimigren 1,2,5-tiadiazolderivater av indolylalkylpyridinyl- og -pyrimidinylpiperaziner
DE69611758D1 (de) N-1-carbocylalkyl derivate von lsd
FI950389A0 (fi) Ny medicinsk anvaendning av hemiprodukter
DE29717551U1 (de) Beutelgebinde, Beutelgebindesortiment und Produktpalette von Beuteln
ATE346840T1 (de) Aminoalkylphenol-derivate zur behandlung von depression und gedächtnis-funktionsstörung
NO982562D0 (no) Sammensetning for behandling av smerte
DE69710305T2 (de) Derivate von 4-Vinyl-4'-alpha-hydroxyethyl-biphenyl
DE69019097D1 (de) Azlactonfunktionen aufweisende Siliciumverbindungen und deren Derivate.
PT796843E (pt) Derivados de 1,25-di-hidroxi-16,22,23-trisde-hidro-colecalciferol
DE3878087T2 (de) 2-hydroxybenzophenon-hydrazide und derivate davon.
FI972674A0 (fi) 3,3-(disubstituoituja)sykloheksan-1-olimonomeerejä ja vastaavia yhdisteitä

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee